Novo Holdings, a leading global healthcare and life sciences investor, has announced a strategic minority investment in Huizhou ForYou Medical Devices, a China-based contract development and manufacturing organisation (CDMO) specialising in advanced wound care products. GL Capital, one of China's leading healthcare-focused private equity firms, will remain the company's majority shareholder..

全球领先的医疗保健和生命科学投资者诺和控股（Novo Holdings）宣布，对总部位于中国的合同研发与生产组织（CDMO）惠州福友医疗器械有限公司进行战略性少数股权投资，该公司专注于先进伤口护理产品。中国领先的专注于医疗保健的私募股权公司之一GL Capital将继续保持其多数股东地位。

The investment reflects Novo Holdings' conviction in the long-term growth of advanced wound care, increasing global demand for specialised healthcare manufacturing, and China's important role in delivering high-quality medical technologies to healthcare companies around the world.

此项投资体现了诺和控股对高端伤口护理领域长期增长的信心，以及对全球专业化医疗健康制造需求日益增长的认可，同时彰显了中国在向全球医疗健康企业提供高质量医疗技术方面所发挥的重要作用。

Headquartered in Huizhou, Guangdong Province, ForYou Medical is a development and manufacturing partner with a comprehensive portfolio of advanced wound care technologies and products.

福友医疗总部位于广东省惠州市，是一家拥有先进伤口护理技术和产品全面组合的研发与制造合作伙伴。

Since its founding in 2005, continuous innovation has been at the core of the company's growth, driving the development of an integrated platform spanning polymer materials and biomaterial research, product development, regulatory affairs and large-scale manufacturing.

自2005年成立以来，持续创新一直是公司增长的核心，推动了一个涵盖高分子材料与生物材料研究、产品开发、监管事务及大规模制造的集成平台的发展。

Advanced wound care is a structurally growing healthcare segment, supported by ageing populations, increasing prevalence of chronic wounds and continued adoption of advanced treatment solutions. As healthcare companies increasingly partner with specialist manufacturers to accelerate innovation, broaden product portfolios and improve operational efficiency, demand for high-quality CDMO partners continues to grow..

先进伤口护理是一个结构性增长的医疗保健领域，其增长得益于人口老龄化、慢性伤口患病率上升以及先进治疗方案的持续普及。随着医疗保健公司日益与专业制造商合作，以加速创新、拓宽产品组合并提高运营效率，对高质量合同研发生产组织（CDMO）合作伙伴的需求持续增长。